A clinically supported option for your patients managing bone health
A clinically supported option for your patients managing bone health
Your patients are already searching for alternatives. When they come to you with questions about osteoporosis medications and their side effects, Marodyne LiV gives you a clinically supported, non-invasive option to point them toward.
We have been working with health technologies for more than 20 years and partner directly with physiotherapists, chiropractors, naturopaths, and other practitioners across Canada.
Patients who may be
suitable for referral
Marodyne LiV may be appropriate for patients who:
Marodyne LiV is not a replacement for medical treatment. We position it as a supportive, non-invasive option to complement the care you are already providing.


How Low-Intensity
Vibration (LiV) works
Low-Intensity Vibration (LiV) is a non-invasive mechanical signal delivered at a specific frequency and low amplitude, transmitted through the skeletal system when a patient stands on the device.
The clinical rationale is grounded in mechano-biology: bone tissue responds to mechanical stimulation. Where high-intensity vibration or high-impact exercise may be contraindicated in frail or post-menopausal populations, LiV delivers a stimulus at a magnitude and frequency considered appropriate for this cohort.
Marodyne LiV delivers vibration at 0.3g and 30 Hz, based on the work of Professor Clinton Rubin and colleagues. Their research has been published in peer-reviewed literature and funded by the National Institutes of Health (NIH) and NASA. We can provide references to relevant literature on request.
Referring a
patient to Marodyne
The process is straightforward. If you believe a patient may benefit:
There is no formal referral form. We work with whatever approach suits your practice.


Writing a prescription
for Marodyne LiV
Prescriptions can be written by physicians, nurse practitioners, physiotherapists, and chiropractors. A prescription may help your patient in two ways:
For insurance claims, the device is most consistently recognised when described as a Marodyne LiV bone stimulator unit. Our team can provide additional guidance on insurer terminology.

